Skip to main content

Breadcrumb

  1. Home

Aggressive B-cell lymphomas of the respiratory system: histologic, immunohistochemical and genetic evaluation of a large series

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Aggressive B-cell lymphomas of the respiratory system: histologic, immunohistochemical and genetic evaluation of a large series

Aggressive B-cell lymphoma in extreme age groups; Review of a series of 760 cases

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Aggressive B-cell lymphoma in extreme age groups; Review of a series of 760 cases

MultiOmyx™ multiplexed tumor infiltrating lymphocyte panel provides comprehensive immunophenotyping from a single FFPE slide

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about MultiOmyx™ multiplexed tumor infiltrating lymphocyte panel provides comprehensive immunophenotyping from a single FFPE slide

Detection of IFNγ induced PD-L1 expression by combined in situ RNA analysis and protein profiling from a single FFPE slide

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Detection of IFNγ induced PD-L1 expression by combined in situ RNA analysis and protein profiling from a single FFPE slide

PD-L1 expression correlates with TP53 gene mutation status in lung cancer but not in colorectal cancer

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about PD-L1 expression correlates with TP53 gene mutation status in lung cancer but not in colorectal cancer

MLL: The gene and its translocation partners. 2 cases with a t(11;17) involving MLL and mimicking the variant t(11;17) RARA translocation

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about MLL: The gene and its translocation partners. 2 cases with a t(11;17) involving MLL and mimicking the variant t(11;17) RARA translocation

Using next generation sequencing of peripheral blood cfDNA as a clinical test in screening for hematologic neoplasms

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Using next generation sequencing of peripheral blood cfDNA as a clinical test in screening for hematologic neoplasms

Interclonal and intraclonal heterogeneity in patients with IDH1/2 mutation

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Interclonal and intraclonal heterogeneity in patients with IDH1/2 mutation

Higher mutation rate in patients with aplastic anemia using peripheral blood cfDNA as compared with bone marrow cells

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Higher mutation rate in patients with aplastic anemia using peripheral blood cfDNA as compared with bone marrow cells

Development and validation of automated flow cytometry system for the diagnosis and prediction of molecular abnormalities in myelodysplastic syndrome

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Development and validation of automated flow cytometry system for the diagnosis and prediction of molecular abnormalities in myelodysplastic syndrome

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • …
  • Next page Next
  • Last page Last
Subscribe to